Current Research Studies
A randomized trial of low versus moderate exposure busulfan for infants with severe combined immunodeficiency (SCID) receiving TCRαβ+/CD19+ depleted transplantation: A Phase II study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC “CSIDE” Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801
8731 C-SIDE
What is the goal of the study?
Busulfan exposure-finding for SCID with TCRαβ+/CD19+ depleted transplantation
Who can participate in the study?
Please contact the study team listed below to learn more.